# Sleepiz One+ Versus Capnography and Electrocardiography

> **NCT05712226** · NA · COMPLETED · sponsor: **Sleepiz AG** · enrollment: 36 (actual)

## Conditions studied

- COPD
- Hypertension
- Sleep Apnea
- Asthma
- Heart Diseases
- Respiratory Disease

## Interventions

- **DEVICE:** Sleepiz One+

## Key facts

- **NCT ID:** NCT05712226
- **Lead sponsor:** Sleepiz AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-22
- **Primary completion:** 2023-04-06
- **Final completion:** 2023-04-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05712226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05712226, "Sleepiz One+ Versus Capnography and Electrocardiography". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05712226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*